| Product Code: ETC6366876 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Belgium continued to see a significant influx of viral vector and vaccine imports, with top exporting countries being the USA, Austria, Netherlands, Hungary, and the UK. The high Herfindahl-Hirschman Index (HHI) indicates a continued concentration of imports among a few key players. Despite a remarkable compound annual growth rate (CAGR) of 39.8% from 2020 to 2024, there was a notable decline in growth from 2023 to 2024, with a negative growth rate of -59.2%. This trend suggests a potential shift or adjustment in the import dynamics within the Belgian market for viral vectors and vaccines.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Viral Vector and Vaccine Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Viral Vector and Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Belgium Viral Vector and Vaccine Market - Industry Life Cycle |
3.4 Belgium Viral Vector and Vaccine Market - Porter's Five Forces |
3.5 Belgium Viral Vector and Vaccine Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Belgium Viral Vector and Vaccine Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Belgium Viral Vector and Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development in the biotechnology sector in Belgium |
4.2.2 Rising prevalence of infectious diseases driving the demand for vaccines |
4.2.3 Technological advancements in viral vector and vaccine development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of viral vector and vaccines |
4.3.2 High cost associated with research, development, and production of viral vectors and vaccines |
5 Belgium Viral Vector and Vaccine Market Trends |
6 Belgium Viral Vector and Vaccine Market, By Types |
6.1 Belgium Viral Vector and Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Viral Vector and Vaccine Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Belgium Viral Vector and Vaccine Market Revenues & Volume, By Adenovirus, 2022 - 2032F |
6.1.4 Belgium Viral Vector and Vaccine Market Revenues & Volume, By Fowlpox Virus, 2022 - 2032F |
6.1.5 Belgium Viral Vector and Vaccine Market Revenues & Volume, By Attenuated Yellow Fever, 2022 - 2032F |
6.1.6 Belgium Viral Vector and Vaccine Market Revenues & Volume, By Vaccinia Virus Vectors, 2022 - 2032F |
6.2 Belgium Viral Vector and Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium Viral Vector and Vaccine Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.2.3 Belgium Viral Vector and Vaccine Market Revenues & Volume, By Biopharmaceutical Companies, 2022 - 2032F |
6.2.4 Belgium Viral Vector and Vaccine Market Revenues & Volume, By Others, 2022 - 2032F |
7 Belgium Viral Vector and Vaccine Market Import-Export Trade Statistics |
7.1 Belgium Viral Vector and Vaccine Market Export to Major Countries |
7.2 Belgium Viral Vector and Vaccine Market Imports from Major Countries |
8 Belgium Viral Vector and Vaccine Market Key Performance Indicators |
8.1 Research funding allocated to viral vector and vaccine development projects in Belgium |
8.2 Number of clinical trials conducted for viral vectors and vaccines in Belgium |
8.3 Adoption rate of newly developed viral vectors and vaccines in the healthcare system |
9 Belgium Viral Vector and Vaccine Market - Opportunity Assessment |
9.1 Belgium Viral Vector and Vaccine Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Belgium Viral Vector and Vaccine Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Belgium Viral Vector and Vaccine Market - Competitive Landscape |
10.1 Belgium Viral Vector and Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Belgium Viral Vector and Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here